R&D Systems Human IL-5 R alpha/CD125 Recombinant Protein
Manufacturer: R&D Systems 2535R025/CF
DescriptionMeasured by its ability to inhibit IL-5-dependent proliferation of TF-1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED 50 for this effect is 0.5-2 µg/mL in the presence of 0.5 ng/mL of rhIL-5.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|97%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|IL-5 R alpha/CD125|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|